Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH

Clinical Endocrinology

Volumn 47, Issue 1, 1997, Pages 43-50

  Kicman, Andrew T ^a   Miell, John P ^b   Teale, J Derrick ^c   Powrie, Jake ^d   Wood, Peter J ^e   Laidler, Paul ^a   Milligan, Peter J ^a   Cowan, David A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DOPING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SPORTS MEDICINE; SUBCUTANEOUS DRUG ADMINISTRATION; URINALYSIS;

EID: 0030841703     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2111036.x     Document Type: Article

References (35)

1. Abramson, F.P., Osborn, B.L & Teffera, Y. (1996) Isotopic differences in human growth hormone preparations. Analytical Chemistry, 68, 1971-1972.
2. Bengtsson, B-A., Edén, S., Lönn, L., Kvist, H., Stockland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism, 76, 309-317.
3. Bergmann P., Valsamis, J., Van Perborgh, J., De Schepper, J. & Van Vliet, G. (1990) Comparative studies of the changes in insulin-like growth faclor-I, procollagen-III N-terminal extension peptide, bone gla-protein, & bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. Journal of Clinical Endocrinology & Metabolism, 71, 1461-1467.
4. Blum, W.F., Horn, N., Kratzsch, J., Jorgensen, J.O.L., Juul, A., Teale, D., Mohnike, K. & Ranke, M.B. (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regulation, 3, 100-104.
5. Cappon, J., Brasel, J.A., Mohan, S. & Cooper, D.M. (1994) Effect of brief exercise on circulating insulin-like growth factor I. Journal of Applied Physiology, 76, 2490-2496.
6. Copeland, K.C., Underwood, L.E. & Van Wyk, J.J. (1980) Induction of immunoreactive somatomedin C in human serum by growth hormone: dose response relationships & effect on chromatographic profiles. Journal of Clinical Endocrinology & Metabolism, 50, 690-697.
7. Cuneo, R.C. & Wallace, J.D. (1994) Growth hormone, insulin-like growth factors & sport. Endocrinology and Metabolism, 1, 3-13.
8. Deyssig, R., Frisch, H., Blum, W.F. & Waldhör, T. (1993) Effect of growth hormone treatment on hormonal parameters, body composition & strength in athletes. Acta Endocrinologica, 128, 313-318.
9. Di Pasquale, M.G. (1990) Growth hormone. In Beyond Anabolic Steroids, pp. 6-16. MGD Press, Ontario.
10. Dollery, C. (ed.) (1991) Somatropin. In Therapeutic Drugs, Vol. 2, pp. S69-S72. Churchill Livingstone, Edinburgh.
11. Duchaine, D. (1989) Human growth hormone. In Underground Steroid Handbook II, pp. 74-76. HLR Technical Books, California.
12. Evans, A.J. & Wood, P.J. (1995) An evaluation of urinary IGF-BP3 measurements in the assessment of short stature in children & of acromegaly in adults. Journal of Endocrinology, 144, (Supplement). P244.
13. Felsing, N.E., Brasel J.A. & Cooper, D.M. (1992) Effect of low & high intensity exercise on circulating growth hormone in men. Journal of Clinical Endocrinology and Metabolism, 75, 157-162.
14. Gargosky, S.E., Hasegawa, T., Tapanainen, P., MacGillivray, M., Hasegawa, Y. & Rosenfeld, R.G. (1993) Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease. Journal of Clinical Endocrinology and Metabolism, 76, 1631-1637.
15. Guler, H-P., Zapf, J., Schmid C. & Froesch E.R. (1989) Insulin-like growth factors I and II in healthy man: estimations of half-lives and production rates. Acta Endocrinologica, 121, 753-758.
16. Hall, K., Lundin, G. & Povoa, G. (1988) Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinologica, 118, 321-326.
17. Hardouin, S., Gourmelen, M., Noguiez, P., Seurin, D., Roghani, M., Le Bouc, Y., Povoa, G., Merimee, T.J., Hossenlopp, P. & Binoux, M. (1989) Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: Relationships with growth hormone and IGFs and physiological significance. Journal of Clinical Endocrinology and Metabolism, 69, 1291-1301.
18. Hasegawa, Y., Cohen P., Yorgin, P. & Rosenfeld, R.G. (1992) Characterisation of urinary insulin-like growth factor binding proteins. Journal of Clinical Endocrinology and Metabolism, 74, 830-835.
19. Hindmarsh, P.C., Matthews, D.R., Brain, C.E., Pringle, P.J., di Silvio, L., Kurtz, A.B. & Brook, C.G.D. (1989) The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin. Clinical Endocrinology, 30, 443-450.
20. Jensen, L.T., Jørgensen, J.O.L., Risteli, J., Christiansen, J.S. & Lorenzen, I. (1991) Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. Acta Endocrinologica, 124, 278-282.
21. Juul, A., Main, K., Blum, W.F., Lindholm, J., Ranke M.B. & Skakkebaek, N.E. (1994) The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology, 41, 85-93.
22. Kicman, A.T. & Cowan, D.A. (1992) Peptide hormones and sport: misuse and detection. British Medical Bulletin, 48, 496-517.
23. Kraemer, W.J., Aguilera, B.A., Terada, M., Newton, R.U., Lynch, J.M., Rosendaal, G., McBride, J.M., Gordon, S.E. & Häkkinen, K. (1995) Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise. Journal of Applied Physiology, 79, 1310-1315.
24. Laidler, P., Hider, R.C., Kicman, A.T. & Cowan, D.A. (1994) New decision limits and quality-control material for detecting human chorionic gonadotropin misuse in sports. Clinical Chemistry, 40, 1306-1311.
25. Laidler, P., Cowan, D.A., Hider, R.C., Keane, A. & Kicman, A.T. (1995) Tryptic mapping of human chorionic gonadotropin by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry, 9, 1021-1026.
26. Lassarre, C., Girard, F., Durand, J. & Rayneud, J. (1974) Kinetics of human growth hormone during submaximal exercise. Journal of Applied Physiology, 37, 826-830.
27. Miell, J.P., Taylor, A.M., Jones, J., Holly, J.M.P., Gaillard, R.C., Pralong, F.P., Ross, R.J.M. & Blum, W.F. (1993) The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. Journal of Endocrinology, 136, 525-533.
28. Saugy, M., Cardis, C. & Rivier, L. (1995a) Urinary human growth hormone (U-HGH): I. Measurements in non-athlete volunteers after intra-muscular or subcutaneous hGH injections. In Proceedings of 12th Cologne Workshop on Dope Analysis (ed. M. Donike, H. Geyer, A. Gotzman & U. Mareck-Engelke), pp. 213-222. Sport und Buch Strauss, Edition Sport, Köln.
29. Saugy, M., Cardis, C., Rivier, L., Brisson, G., Ayotte, C., Hemmersbach, P., Haug, E. & Segura, J. (1995b) Urinary human growth hormone (U-HGH): II. Measurements in competition tests: more the expression of the renal function than the endocrinological status. In Proceedings of 12th Cologne Workshop on Dope Analysis (ed. M. Donike, H. Geyer, A. Gotzman & U. Mareck-Engelke), pp. 223-234. Sport und Buch Strauss, Edition Sport, Köln.
30. Sartorio, A., Conti, A. & Monzani, M. (1993) New markers of hone and collagen turnover in children and adults with growth hormone deficiency. Postgraduate Medical Journal, 69, 846-850.
31. Schmidt, W., Doré, S., Hilgendorf, A., Strauch S., Gareau, R. & Brisson, G.R. (1995) Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis. European Journal of Applied Physiology, 71, 424-430.
32. Teale, J.D. & Marks, V. (1990) Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia. Clinical Endocrinology, 33, 87-98.
33. Tönshoff, B., Blum, W., Vickers, M., Kurilenko S., Mehls, O. & Ritz, E. (1995) Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone. European Journal of Endocrinology, 132, 433-437.
34. Wood, P.J. (1996) Experience with the Immulite serum GH assay. In Proceedings of UK NEQAS Endocrinology Meeting: EQAS'96, Cardiff, UK, 31 March-3 April 1996 (ed. C.M. Sturgeon, J. Seth, J. Middle & S.P. Halloran), p. 25. ACB Publications, Dorchester, UK.
35. Young, S.C.J., Miles, M.V. & Clemmons, D.R. (1992) Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-I and -2 in rats. Endocrinology, 131, 1867-1873.